Col3a1 - OmicsDI

Show results for

Unknown (609)
Transcriptomics (104)
Genomics (96)
Proteomics (20)
Other (4)
Metabolomics (1)

Organisms

Mus musculus (52)
Homo sapiens (48)
Chlamydomonas reinhardtii (15)
Marchantia polymorpha subsp. ruderalis (15)
Methylocystis sp. (15)
Bothrops insularis (15)
Bothrops jararaca (15)
Bothrops jararacussu (15)
Bothrops cotiara (15)
Streptomyces coelicolor (15)
Burkholderia ubonensis MSMB22 (15)
Pseudomonas aeruginosa PA103 (15)
Artibeus jamaicensis (15)
Morchella importuna (15)
Bothrops brazili (15)
Ixodes scapularis (15)
Bothrops leucurus (15)
Bothrops moojeni (15)
Pseudomonas syringae (15)
Sclerotinia sclerotiorum (15)
Rattus norvegicus (7)
Canis lupus familiaris (2)
Anolis carolinensis (1)
Ambystoma mexicanum (1)
synthetic construct (1)
blank sample (1)
Bos taurus (1)
Sus scrofa (1)
Gallus gallus (1)
Bos grunniens (1)

Organisms

Mus musculus (38)
Homo sapiens (37)
Rattus norvegicus (4)
Anolis carolinensis (1)
Ambystoma mexicanum (1)
Canis lupus familiaris (1)
Sus scrofa (1)
Bos taurus (1)

Repository

ENA (92)
geo (85)
biostudies-arrayexpress (27)
pride (15)
LINCS (10)
iProX (3)
MassIVE (2)
MetaboLights (1)

Tissue

Peritubular myoid cell (3)
Cell culture (3)
Antler (1)
Fibroblast of cardiac tissue (1)
Aorta (1)
Mesenchymal stem cell of the bone marrow (1)
Tooth (1)
Tooth enamel (1)
Urine (1)
Skin (1)
Bone marrow (1)
Blood serum (1)
Blood plasma (1)
Fibroblast (1)

Disease

Ureteral obstruction (1)
Parkinson's disease (1)
Osteoarthritis (1)
Chronic kidney disease (1)
Disease free (1)

Technology Type

Mass Spectrometry (15)
MEMA (10)
Fluorescence intensity (10)
Shotgun proteomics (7)
Data-dependent acquisition (3)
Bottom-up proteomics (3)
SWATH MS (2)
Data-independent acquisition (2)
Mass spectrometry assay (1)
Gel-based experiment (1)

Instrument Platform

TimsTOF fleX (1)
Q Exactive HF-X (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (20)
2026 (17)
2023 (14)
2024 (12)
2022 (11)
2016 (11)
2012 (7)
2010 (7)
2021 (7)
2015 (6)
2009 (5)
2020 (5)
2014 (4)
2006 (4)
2008 (3)
2013 (2)
2011 (2)
2018 (2)
2007 (1)
2017 (1)
2019 (1)

Metabolite Name

Coumaphos syn-dimer (1)
(2S,3R,4R,5S,6S)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate (1)
Pip(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
Sodium 1-[2-deoxy-5-O-(hydroxyphosphinato)pentofuranosyl]-5-fluoropyrimidine-2,4(1H,3H)-dione (1)
Terrestrin D (1)
Zinnimide (1)
2-methyl-3-hydroxybutyryl-CoA (1)
Prolylprolyllysine (1)
Ridiculuflavone B (1)
S-(5-Deoxy-D-ribos-5-yl)-L-homocysteine (1)
(2S,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]oxy-4-hydroxy-3,5-disulfooxyoxane-2-carboxylic acid (1)
N-(Adamant-1-yl)-6-isopropyl-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide (1)
Methyl (1R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-10,11-dihydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate (1)
Trans-Feruloyl-CoA (1)
Delta-Anaerubin (1)
2-{[(4-Chloro-2-methylphenoxy)acetyl]amino}benzoic acid (1)
Myricetin 3-O-beta-D-galactoside 6''-O-gallate (1)
Jnj-42041935 (1)
6-{3-[6-(3,4-dihydroxy-6-methyl-5-oxooxan-2-yl)-5,7-dihydroxy-4-oxo-4H-chromen-2-yl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
[5-[5,7-Dihydroxy-6-[4-hydroxy-6-methyl-5-oxo-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]-4-oxochromen-2-yl]-2-hydroxyphenyl] hydrogen sulate (1)
6-{5-[6-(3,4-dihydroxyphenyl)-8,13-dihydroxy-4-oxo-3,11-dioxatricyclo[8.4.0.0(2),]tetradeca-1(10),2(7),8-trien-12-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
DTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose (1)
Fusaproliferin (1)
{[(2R,3S,4R,5S)-3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]methoxy}phosphonic acid (1)
3-(2,5-dihydroxy-4-methoxyphenyl)-5,6,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (1)
3-Hydroxy-L-tyrosyl-AMP (1)
6-{[5,7-dihydroxy-4-oxo-2-phenyl-8-(3,4,5-trihydroxyoxan-2-yl)-4H-chromen-6-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
3-[(9E,12E)-octadeca-9,12-dienoyloxy]-4-(trimethylazaniumyl)butanoate (1)
4-Methyl-5-hydroxyethylthiazole phosphate (1)
2,3,4-Trimethoxyhippuric acid (1)

First Public Date

2025 (17)
2026 (13)
2014 (12)
2023 (11)
2022 (11)
2024 (10)
2021 (5)
2020 (5)
2015 (4)
2018 (2)
2017 (1)
2016 (1)

Study type

Transcription profiling by array (27)

Release Date

2025 (74)
2021 (71)
2022 (70)
2023 (67)
2020 (64)
2024 (57)
2019 (36)
2017 (26)
2015 (23)
2018 (22)
2016 (18)
2013 (16)
2012 (15)
2010 (14)
2014 (13)
2011 (10)
2026 (8)
2009 (7)
2007 (5)
2008 (4)
2006 (3)
2005 (1)
2002 (1)
2001 (1)

Lab affiliation

Laboratory for Functional Genome Analysis LAFUGA, Gene Center, LMU München, München, Germany, Feodor-Lynen-Straße 25, 81377 München (2)
Chair Plant Biotechnology Faculty of Biology University of Freiburg Schaenzlestrasse 1 D-79104 Freiburg Germany (1)
Department of Biosciences, Durham University, UK (1)
Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands (1)
Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences (1)
Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, Toulouse, France. (1)
1. Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Department of Neurology, Fuzhou 350108, China 2.School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China (1)
Department of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, No. 172, Tongzipo road, Yuelu District, Changsha 410013, Hunan Province, China (1)
Director, NCI-Designated Cancer Center Professor, Cancer Metabolism and Microenvironment Program Sanford Burnham Prebys Medical Discovery Institute 10901 North Torrey Pines Road La Jolla, CA 92037 (1)
1Laboratory for Functional Genome Analysis LAFUGA, Gene Center, LMU München, München, Germany, Feodor-Lynen-Strasse 25, 81377 München (1)
MSAP UAR 3290 CNRS bat C4 avenue paul langevin 59655 villeneuve d'ascq cité scientifique (1)
Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (1)
Department of Rehabilitation Medicine, Nanfang Hospital of Southern Medical University, Guangzhou 510000, China. (1)
King's College London (1)

Previous page
1 / 84
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 84
Next page

Sort by:

Relevance

Page size

RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.

RNF185 is a RING finger domain-containing ubiquitin ligase implicated in ER-associated degradation. Prostate tumor patient data analysis revealed a negative correlation between RNF185 expression and prostate cancer progression and metastasis. Likewise, several prostate cancer cell lines exhibited gr...

ORGANISM(S): Mus musculus (Mouse)

2024-08-09 | PXD045473 | Pride

The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene

Systemic sclerosis (SSc) is a polygenic, autoimmune disorder of unknown etiology, characterized by the excessive accumulation of extracellular matrix (ECM) proteins, vascular alterations, and autoantibodies. The tight skin (Tsk)2/+ mouse model of SSc demonstrates signs similar to SSc including ti...

ORGANISM(S): Mus musculus

2015-09-24 | E-GEOD-61728 | biostudies-arrayexpress

RNF185 control of COL3A1 expression impacts prostate cancer migration and metastatic potential

PRJNA952534 | ENA

RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential

ORGANISM(S): Homo sapiens

2023-10-18 | GSE245708 | GEO

RNF185 control of COL3A1 expression impacts prostate cancer migration and metastatic potential

RNF185 is a RING finger domain-containing ubiquitin ligase implicated in ER associated degradation. Analysis of prostate tumor patient data revealed a negative correlation between RNF185 expression and prostate cancer progression and metastasis. Likewise, several prostate cancer cell lines exhibited...

ORGANISM(S): Mus musculus

2024-02-14 | GSE228999 | GEO

RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential.

Not available

S-EPMC10841372 | biostudies-literature

COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.

Not available

S-EPMC5342568 | biostudies-literature

COL3A1: Potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing.

Not available

S-EPMC9972170 | biostudies-literature

Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.